Abstract
Purpose
The objective of this study was to analyze hyperreflective foci at the vitreous-retinal interface in cases of idiopathic epiretinal membrane (iERM) using enface-OCT.
Methods
This study included 47 patients (52 eyes) diagnosed with iERM between January 2020 and July 2023. We observed changes in hyperreflective foci in the macular area at each stage of iERM using OCTA on a 6 mm slab of the VRI. Evaluations included the density and percentage of hyperreflective foci of the epiretinal membrane at each stage, as well as the relationship between hyperreflective foci density and other OCT parameters, such as macular thickness and changes in macular superficial vascular density.
Results
Statistically significant differences in hyperreflective foci density and percentage were observed across the four stages of patients (p < 0.05). Additionally, statistically significant differences in superficial vascular density were noted among the four stages (p < 0.05). Hyperreflective foci area percentage and density correlated significantly with hyperreflective foci, FAZ area, and FAZ perimeter (p < 0.005). However, no correlation was found between hyperreflective foci density and area percentage with superficial vascular density and superficial perfusion density (p > 0.05).
Conclusion
Hyperreflective foci were identified in all stages of iERM, with their number and density increasing as the disease progressed.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer




